IP Library Granted Patent US 10,668,312
Granted Patent B2
US 10,668,312 · App. 16/456,958 · Granted Jun 2, 2020

Controlled medication denaturing composition

Inventors: Justin Stas (John's Island, SC); Yizhong Wang (Ann Arbor, MI); Evan Boyst (Belleville, MI); Venkata S. Reddy Channu (Ypsilanti, MI); Emma Leishman (Ann Arbor, MI)
Assignee: Okra Medical, Inc.
A62D3/38A62D2101/22A62D2101/26A62D2101/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,668,312
App. No.
16/456,958
Granted
Jun 2, 2020
Kind
B2
Abstract

A composition for decomposing pharmaceutically active agents, comprises up to 30 wt. % oxidizer; and up to 30 wt. % immobilizer; wherein the wt. % is based on a total weight of the composition.

Claims (27)

1. A composition for decomposing controlled substances, comprising:

an oxidizer an oxidizer comprising potassium permanganate in combination with:

sodium dichloroisocyanurate dihydrate, potassium dichloroisocyanurate dihydrate, trichloroisocyanuric acid, dichloroisocyanuric acid, or any combination thereof; and

up to 30 wt. % immobilizer;

wherein the wt. % is based on a total weight of the composition.

2. The composition of claim 1 , wherein the oxidizer comprises potassium permanganate, sodium dichloroisocyanurate dehydrate, and trichloroisocyanuric acid.

3. The composition of claim 2 , wherein the oxidizer comprises:

0.1 to 8 wt. % potassium permanganate;

up to 25 wt. % sodium dichloroisocyanurate dehydrate; and

up to 7 wt. % trichloroisocyanuric acid.

4. The composition of claim 1 , wherein the immobilizer comprises a gelatin, an agarose, a starch, a vegetable gum, a cellulose, a cellulose derivative, a carbomer, a polyvinylpyrrolidone, polyethylene oxide, polyethylene glycol, an alginate, guar gum, xanthan gum, a saccharide, an amylopectin, Arabic gum, a polyacrylic acid, or any combination thereof.

5. The composition of claim 1 , wherein the immobilizer comprises xanthan gum.

6. The composition of claim 5 , wherein the xanthan gum comprises 8-30 wt. % of the composition.

7. The composition of claim 6 , further comprising a multivalent alkaline earth metal-based chloride.

8. The composition of claim 7 , wherein the multivalent alkaline earth metal-based chloride is CaCl 2 , MgCl 2 , BaC 1 2 , or mixtures thereof present up to 5 wt. % of the composition.

9. The composition of claim 1 , further comprising a solidifier comprising a clay, a silica, a sand, or any combination thereof.

10. The composition of claim 9 , wherein the clay is present up to 25 wt. %; the silica is present up to 25 wt. %; and/or the sand is present up to 25 wt. %.

11. A composition comprising:

up to 8 wt. % potassium permanganate;

up to 25 wt. % sodium dichloroisocyanurate dehydrate; and

up to 7 wt. % trichloroisocyanuric acid;

wherein the wt. % is based on a total weight of the composition.

12. The composition of claim 11 , further comprising one or more of:

up to 25 wt. % clay;

up to 25 wt. % silica; and

up to 25 wt. % sand.

13. The composition of claim 11 , further comprising up to 7 wt. % of CaCl 2 , MgCl 2 , BaC 1 2 , or mixtures thereof.

Assignments (2)
CHANGE OF NAME Recorded Jun 4, 2024
From: OKRA MEDICAL, INC.
To: SAFEMEDWASTE, INC.
Reel/Frame 067637/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2019
From: STAS, JUSTIN; WANG, YIZHONG; BOYST, EVAN; CHANNU, VENKATA S. REDDY; LEISHMAN, EMMA
To: OKRA MEDICAL, INC.
Reel/Frame 049842/0703 →
Continuity (4)
Continuation PCTUS2019037742 · Jun 18, 2019
Provisional Application 62792762 · Jan 15, 2019
Provisional Application 62740625 · Oct 3, 2018
Related Publication 20200108286A1 · Apr 9, 2020